Columbia Laboratories, Molecular Profiles deal

Columbia Labs acquired CRO Molecular Profiles for $25 million comprising $16.7 million in cash and 1.1 million Columbia shares. Molecular Profiles CEO and co-founder Nikin Patel joins Columbia's board. Molecular Profiles performs contract R&D, clinical trial manufacturing and analysis and consulting. Molecular Profiles had about $9 million in revenue for the fiscal year ended July 31, and Columbia had $14.3 million in revenue for the six months ended June 30. ...